Faron Pharmaceuticals Oy (FARN):企業の財務・戦略的SWOT分析

◆英語タイトル:Faron Pharmaceuticals Oy (FARN) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH207093FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フィンランド
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥66,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥99,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Faron Pharmaceuticals Oy (Faron) is a clinical stage biopharmaceutical company that develops treatments for unmet medical needs. The company is developing pipeline products with a focus on vascular damage, acute organ traumas and cancer immunotherapy. It offers Clevegen, a humanized Clever-1 antibody, that coverts immune suppressive M2 macrophages to immune stimulating M1 macrophages. and Traumakine, used for treatment of acute respiratory distress syndrome and rupture of abdominal aorta aneurysm. Faron’s Traumakine aims to prevent vascular leakage and organ failure. The company works in collaboration with academic institutions, pharmaceutical companies and contract research organizations for clinical development programmes. Faron is headquartered in Turku, Finland.

Faron Pharmaceuticals Oy Key Recent Developments

Mar 27,2021: Faron Pharmaceuticals Oy : Financial statement release January 1 to December 31, 2020
Mar 25,2021: Financial statement January 1 to December 31 2020
Sep 24,2020: Faron Pharmaceuticals Oy: Half-year report for 1 January to 30 June 2020
Jun 16,2020: Faron hosts virtual R&D Day today

This comprehensive SWOT profile of Faron Pharmaceuticals Oy provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Faron Pharmaceuticals Oy including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Faron Pharmaceuticals Oy – Key Information
Faron Pharmaceuticals Oy – Overview
Faron Pharmaceuticals Oy – Key Employees
Faron Pharmaceuticals Oy – Key Employee Biographies
Faron Pharmaceuticals Oy – Key Operational Heads
Faron Pharmaceuticals Oy – Major Products and Services
Faron Pharmaceuticals Oy – History
Faron Pharmaceuticals Oy – Company Statement
Faron Pharmaceuticals Oy – Locations And Subsidiaries
Faron Pharmaceuticals Oy
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Faron Pharmaceuticals Oy – Business Description
Faron Pharmaceuticals Oy – Corporate Strategy
Faron Pharmaceuticals Oy – SWOT Analysis
SWOT Analysis – Overview
Faron Pharmaceuticals Oy – Strengths
Faron Pharmaceuticals Oy – Weaknesses
Faron Pharmaceuticals Oy – Opportunities
Faron Pharmaceuticals Oy – Threats
Faron Pharmaceuticals Oy – Key Competitors

Section 3 – Company Financial Performance Charts

Faron Pharmaceuticals Oy – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Faron Pharmaceuticals Oy, Key Information
Faron Pharmaceuticals Oy, Key Ratios
Faron Pharmaceuticals Oy, Share Data
Faron Pharmaceuticals Oy, Major Products and Services
Faron Pharmaceuticals Oy, History
Faron Pharmaceuticals Oy, Key Employees
Faron Pharmaceuticals Oy, Key Employee Biographies
Faron Pharmaceuticals Oy, Key Operational Heads
Faron Pharmaceuticals Oy, Other Locations
Faron Pharmaceuticals Oy, Subsidiaries
Faron Pharmaceuticals Oy, Key Competitors
Faron Pharmaceuticals Oy, SWOT Analysis
Faron Pharmaceuticals Oy, Ratios based on current share price
Faron Pharmaceuticals Oy, Annual Ratios
Faron Pharmaceuticals Oy, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Faron Pharmaceuticals Oy (FARN):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Aoyama Trading Co., Ltd.:企業の戦略・SWOT・財務分析
    Aoyama Trading Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Aoyama Trading Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Coloplast A/S:戦略・SWOT・企業財務分析
    Coloplast A/S - Strategy, SWOT and Corporate Finance Report Summary Coloplast A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Mohawk Industries, Inc.:企業の戦略・SWOT・財務分析
    Mohawk Industries, Inc. - Strategy, SWOT and Corporate Finance Report Summary Mohawk Industries, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • COWI AS:企業の戦略的SWOT分析
    COWI AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • General Dynamics Corporation:戦略・SWOT・企業財務分析
    General Dynamics Corporation - Strategy, SWOT and Corporate Finance Report Summary General Dynamics Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • P.T. Telekomunikasi Selular:企業の戦略・SWOT・財務情報
    P.T. Telekomunikasi Selular - Strategy, SWOT and Corporate Finance Report Summary P.T. Telekomunikasi Selular - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • SurModics Inc (SRDX):企業の財務・戦略的SWOT分析
    SurModics Inc (SRDX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • E-CO Energi Holding AS-エネルギー分野:企業M&A・提携分析
    Summary E-CO Energi Holding AS (E-CO Energi) owned by the City of Oslo is an energy company. It owns, operates and develops hydroelectric plants. The company is the second largest hydropower producer in Norway. E-CO Energi also carries out the business development in energy and related fields. The c …
  • DASAN ZHONE SOLUTIONS, INC.:企業の戦略・SWOT・財務情報
    DASAN ZHONE SOLUTIONS, INC. - Strategy, SWOT and Corporate Finance Report Summary DASAN ZHONE SOLUTIONS, INC. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • QVC Inc:企業の戦略的SWOT分析
    QVC Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Hetero Drugs Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Hetero Drugs Ltd (Hetero) is a manufacturer of active pharmaceutical ingredients, intermediate chemicals and finished dosages. The company specializes in process chemistry, API manufacturing, formulation development, manufacturing and commercialization of bio-generics, and also offers custom …
  • Crescent Point Energy Corp (CPG):石油・ガス:M&Aディール及び事業提携情報
    Summary Crescent Point Energy Corp (Crescent Point) is an oil and gas company. It acquires, explores, develops and produces light and medium crude oil, heavy crude oil, tight oil, natural gas liquids, shale gas and conventional natural gas. The company holds interest in light and medium oil and natu …
  • EDP – Energias de Portugal, SA:戦略・SWOT・企業財務分析
    EDP - Energias de Portugal, SA - Strategy, SWOT and Corporate Finance Report Summary EDP - Energias de Portugal, SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Colonial Group Inc.:企業の戦略・SWOT・財務分析
    Colonial Group Inc. - Strategy, SWOT and Corporate Finance Report Summary Colonial Group Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Cavitation Technologies Inc (CVAT):企業の財務・戦略的SWOT分析
    Summary Cavitation Technologies Inc (Cavitation) is an energy service company that develops processing technologies. The company processes fluidic mixtures, liquids, emulsions and suspended solids. Its technology uses hydrodynamic cavitation that comprise fluid’s vaporization and growth, pulsation, …
  • Washington University School of Medicine-製薬・医療分野:企業M&A・提携分析
    Summary Washington University School of Medicine (WUSTL), a subsidiary of University of Washington is a medical university that offers patient care, research, education services and neurology clinical trials. The university provides patient care services such as clinical, find a doctor, referring ph …
  • TOP Ships Inc (TOPS):石油・ガス:M&Aディール及び事業提携情報
    Summary TOP Ships Inc (Top Ships), formerly known as Top Tankers Inc., is a provider of international seaborne transportation services. It owns and operates eco medium range (MR) tanker vessels focusing on the transportation of petroleum products, crude oil and bulk liquid chemicals. The company ser …
  • Avon Rubber Plc (AVON):企業の財務・戦略的SWOT分析
    Avon Rubber Plc (AVON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Recordati S.p.A.:企業のM&A・事業提携・投資動向
    Recordati S.p.A. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Recordati S.p.A. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Allscripts Healthcare Solutions Inc (MDRX):企業の財務・戦略的SWOT分析
    Allscripts Healthcare Solutions Inc (MDRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆